These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36579370)

  • 21. Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.
    Barnitz RA; Chaigne-Delalande B; Bolton DL; Lenardo MJ
    PLoS One; 2011; 6(9):e24924. PubMed ID: 21949789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.
    Pham TN; Richard J; Gerard FC; Power C; Cohen ÉA
    J Virol; 2011 Dec; 85(23):12254-61. PubMed ID: 21957298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
    Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
    Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.
    Liang Z; Liu R; Lin Y; Liang C; Tan J; Qiao W
    Virol Sin; 2015 Dec; 30(6):441-8. PubMed ID: 26676942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC.
    Du L; Wang L; Yu T; Xin R; Meng Z
    Curr HIV Res; 2020; 18(3):165-171. PubMed ID: 32096745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.
    Taneichi D; Iijima K; Doi A; Koyama T; Minemoto Y; Tokunaga K; Shimura M; Kano S; Ishizaka Y
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):177-87. PubMed ID: 21519849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and purification of soluble HIV-2 viral protein R (Vpr) using a sandwich-fusion protein strategy.
    Hänel K; Möckel L; Brummel M; Peiris K; Hartmann R; Dingley AJ; Willbold D; Loidl-Stahlhofen A
    Protein Expr Purif; 2014 Mar; 95():156-61. PubMed ID: 24380802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.
    Soares R; Rocha G; Meliço-Silvestre A; Gonçalves T
    Rev Med Virol; 2016 Sep; 26(5):314-29. PubMed ID: 27264019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.
    Godet AN; Guergnon J; Croset A; Cayla X; Falanga PB; Colle JH; Garcia A
    PLoS One; 2010 Nov; 5(11):e13760. PubMed ID: 21072166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.
    Sharifi HJ; Furuya AK; Jellinger RM; Nekorchuk MD; de Noronha CM
    J Virol; 2014 Jun; 88(12):6944-58. PubMed ID: 24719410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.
    Lum JJ; Cohen OJ; Nie Z; Weaver JG; Gomez TS; Yao XJ; Lynch D; Pilon AA; Hawley N; Kim JE; Chen Z; Montpetit M; Sanchez-Dardon J; Cohen EA; Badley AD
    J Clin Invest; 2003 May; 111(10):1547-54. PubMed ID: 12750404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vpr-host interactions during HIV-1 viral life cycle.
    Zhao RY; Li G; Bukrinsky MI
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):216-29. PubMed ID: 21318276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
    Rossenkhan R; MacLeod IJ; Brumme ZL; Magaret CA; Sebunya TK; Musonda R; Gashe BA; Edlefsen PT; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1031-1045. PubMed ID: 27349335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
    Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
    DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
    J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr.
    Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC
    J Gen Virol; 2009 Nov; 90(Pt 11):2768-2776. PubMed ID: 19605589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
    Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
    J Virol; 2017 May; 91(9):. PubMed ID: 28202763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
    Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
    J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.